Literature DB >> 28933621

Neisseria meningitidis Serogroup X ST-5799 (ST-22 complex) in Turkey: A unique pediatric case.

Gönül Tanır1, Yasemin Ozsurekci2, Jay Lucidarme3, Sevgi Yaşar Durmuş1, Aiswarya Lekshmi3, Özlem Akisoglu4, Ahmet Emre Aycan2, Ray Borrow3, Mehmet Ceyhan2.   

Abstract

Although outbreaks of Neisseria meningitidis serogroup X occured in a couple of African countries, a limited number of serogroup X meningococcal cases were reported in America and Europe as well as Turkey. Additionally, serogroup X is still not represented in current conjugated meningococcal vaccines. Here, we describe the first pediatric case with meningitis caused by Neisseria meningitidis serogroup X ST-5799 (ST-22 complex) that formed a distinct lineage.

Entities:  

Keywords:  Turkey; menengitis; pediatrics; phylogenetic network; sequence analyses

Mesh：

Substances：

Year:  2017        PMID： 28933621      PMCID： PMC5791565          DOI： 10.1080/21645515.2017.1377380

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


  18 in total

Review 1.  Meningococcal disease.

Authors:  N E Rosenstein; B A Perkins; D S Stephens; T Popovic; J M Hughes
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

2.  Rising incidence of invasive meningococcal disease caused by Neisseria meningitidis serogroup W in Victoria.

Authors:  Katherine A Bond; Kerrie Stevens; Dieter Bulach; Kylie Carville; Katherine S Ong; Benjamin P Howden
Journal:  Med J Aust       Date:  2016-04-18       Impact factor: 7.738

3.  Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales.

Authors:  Shamez N Ladhani; Kazim Beebeejaun; Jay Lucidarme; Helen Campbell; Steve Gray; Ed Kaczmarski; Mary E Ramsay; Ray Borrow
Journal:  Clin Infect Dis       Date:  2014-11-10       Impact factor: 9.079

4.  Genetic Analysis of Neisseria meningitidis Sequence Type 7 Serogroup X Originating from Serogroup A.

Authors:  Bingqing Zhu; Pingping Yao; Leyi Zhang; Yuan Gao; Li Xu; Na Xie; Zhujun Shao
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

5.  Meningitis caused by Neisseria Meningitidis, Hemophilus Influenzae Type B and Streptococcus Pneumoniae during 2005-2012 in Turkey. A multicenter prospective surveillance study.

Authors:  Mehmet Ceyhan; Nezahat Gürler; Yasemin Ozsurekci; Melike Keser; Ahmet Emre Aycan; Venhar Gurbuz; Nuran Salman; Yildiz Camcioglu; Ener Cagri Dinleyici; Sengul Ozkan; Gulnar Sensoy; Nursen Belet; Emre Alhan; Mustafa Hacimustafaoglu; Solmaz Celebi; Hakan Uzun; Ahmet Faik Oner; Zafer Kurugol; Mehmet Ali Tas; Denizmen Aygun; Eda Karadag Oncel; Melda Celik; Olcay Yasa; Fatih Akin; Yavuz Coşkun
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

6.  Clonal groupings in serogroup X Neisseria meningitidis.

Authors:  Sébastien Gagneux; Thierry Wirth; Abraham Hodgson; Ingrid Ehrhard; Giovanna Morelli; Paula Kriz; Blaise Genton; Tom Smith; Fred Binka; Gerd Pluschke; Mark Achtman
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

7.  Acquisition of meningococcal serogroup W-135 carriage in Turkish Hajj pilgrims who had received the quadrivalent meningococcal polysaccharide vaccine.

Authors:  M Ceyhan; M Celik; E T Demir; V Gurbuz; A E Aycan; S Unal
Journal:  Clin Vaccine Immunol       Date:  2012-11-07

8.  BIGSdb: Scalable analysis of bacterial genome variation at the population level.

Authors:  Keith A Jolley; Martin C J Maiden
Journal:  BMC Bioinformatics       Date:  2010-12-10       Impact factor: 3.169

9.  Hierarchical genomic analysis of carried and invasive serogroup A Neisseria meningitidis during the 2011 epidemic in Chad.

Authors:  Kanny Diallo; Kadija Gamougam; Doumagoum M Daugla; Odile B Harrison; James E Bray; Dominique A Caugant; Jay Lucidarme; Caroline L Trotter; Musa Hassan-King; James M Stuart; Olivier Manigart; Brian M Greenwood; Martin C J Maiden
Journal:  BMC Genomics       Date:  2017-05-22       Impact factor: 3.969

10.  Serogroup X in meningococcal disease, Western Kenya.

Authors:  Sadiki Materu; Helen S Cox; Petros Isaakidis; Bienvenu Baruani; Thomas Ogaro; Dominique A Caugant
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.